G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/573 (2006.01) C12Q 1/37 (2006.01) G01N 33/86 (2006.01)
Patent
CA 2318740
The existence and the extent of periodontal disease can be diagnosed by measuring plasminogen activator inhibitor 2 (PAI-2) and/or tissue plasminogen activator (t-PA) levels in gingival crevicular fluid (GCF). Levels of PAI-2 and t-PA in GCF rise sharply in the context of periodontal disease, and they also correlate with the severity of disease at different sites in the same patient.
Selon cette invention, il est possible de diagnostiquer l'existence et l'étendue de la parodontopathie en mesurant les taux d'inhibiteurs 2 (PAI-2) de l'activateur du plasminogène et/ou de l'activateur (t-PA) du plasminogène de type tissulaire dans le fluide gingival. L'augmentation brusque des taux de PAI-2 et t-PA dans le fluide gingival indiquent la présence de la parodontopathie, ces taux ayant également une corrélation avec la gravité de la maladie au niveau de différents sites chez le même patient.
Bartold Peter M.
Bunn Clive L.
Xiao Yin
Bereskin & Parr
Biotech Australia Pty. Limited
LandOfFree
Pai-2 and t-pa as diagnostic markers of periodontal disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pai-2 and t-pa as diagnostic markers of periodontal disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pai-2 and t-pa as diagnostic markers of periodontal disease will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1580150